Microdose Psychedelic Insights Announces Call for Speakers for Its Upcoming LSD Conference

Toronto, Ontario--(Newsfile Corp. - January 24, 2022) - Microdose Psychedelic Insights ("Microdose") has opened its Call for Speakers for the LSD Molecular Masterclass, which will be held virtually on February 17 starting at 1:30pm EST. Presenting a scientific deep-dive into the dynamic field of LSD therapeutics, this event is a premier opportunity for speakers to share research, history, culture, medical benefits, and future of this crucial psychedelic compound.

The hundreds of attendees will have the opportunity to attend sessions on: Therapeutic Use of LSD in Psychiatry, Posology and Tolerance to Regression, Safety and Efficacy of Lysergic Acid Diethylamide Assisted Psychotherapy, LSD Microdosing, Effect of Lysergic Acid Diethylamide (LSD) on Learning, The Effects of LSD on Creativity - and more.

Those interested in presenting at LSD Molecular Masterclass may complete the application to become a speaker.

Headline sponsor of the event is MindBio Therapeutics a clinical stage drug development company conducting research into microdosing and medicinal use of psychedelic medicines to treat a range of debilitating mental health conditions.

Companies interested in sponsoring the event may reach out to Daniela Pauli for more details or book a call.

About Molecular Masterclass Conference Series

The Molecular Masterclass is a speaker series designed for deep dives into the world's favorite psychoactive and psychedelic substances.

Previous events included: The Ketamine Conference, The Ibogaine Conference, The Mushroom Conference, and The MDMA Conference.

Additional information about LSD Masterclass, including registration details, speakers are available at https://microdose.buzz/lsd-conference.

NOTES TO EDITORS:

About Microdose Psychedelic Insights

Microdose Psychedelic Insights aims to unlock the potential of psychedelics through Industry events, market intelligence, original, evidence-based content, strategy and community. We enable and empower society at large to make better, more mindful decisions about psychedelics and its intersection with healthcare, medicine and personal growth. We work with the industry's most influential stakeholders, some of the world's best-known brands and an unrivalled network of scientists, researchers, analysts, innovators, investors and advisors.

Press Contact: kristina@microdose.buzz

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/111232